financetom
Market
financetom
/
Market
/
See higher demand for crude in second half of the year, says Edward Morse of Citi
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
See higher demand for crude in second half of the year, says Edward Morse of Citi
Aug 24, 2019 10:49 AM

Edward Morse, managing director and Global Head-Commodities of Citi, in an interview with CNBC-TV18, said that crude demand will climb higher in the second half of the year. He said most of the demand for crude would come in from South Asia, East Asia.

Share Market Live

NSE

Talking about India, he said, "The economic outlook still looks healthy for India, so expect a pickup in demand from there."

The commodities in the week gone by were quite volatile. Crude prices gained, up by about 2.5 percent for Brent, while the US Crude was up by 1 percent. Supply-side pressures seem to be supporting crude oil prices but haven’t been a strong supportive factor.

Most of the industrial metal prices declined. Copper prices are trading at close to two-year lows, while zinc prices are close to three-year lows and iron ore prices have also continued to decline to five-month lows. However, it has been a week of breather for precious metals silver and gold prices after hitting record highs in many currencies for the month of August.

According to him, the crude market has gone relatively short — the relationships between longs and shorts in the market is almost at historical low and that has been putting pressure on crude prices much more than the fundamentals. “For now we think it's US-China trade war and what the US Fed will do in September would be the major driver of this market."

“Look at Brent being in a USD 60/barrel range through the end of the year but that depends on many other things — on September 1, US will be putting more tariffs on imports from China and if China retaliates then it will be negative for all commodities," Morse added.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sector Update: Financial
Sector Update: Financial
May 6, 2024
03:32 PM EDT, 05/06/2024 (MT Newswires) -- Financial stocks advanced in late Monday afternoon trading with the NYSE Financial Index adding 0.8% and the Financial Select Sector SPDR Fund (XLF) rising 0.9%. The Philadelphia Housing Index climbed 1.3%, and the Real Estate Select Sector SPDR Fund (XLRE) fell 0.3%. Bitcoin (BTC-USD) declined 1.4% to $63,057, and the yield for 10-year...
Equity Markets Higher as Traders Parse Fed Official's Remarks
Equity Markets Higher as Traders Parse Fed Official's Remarks
May 6, 2024
03:43 PM EDT, 05/06/2024 (MT Newswires) -- US benchmark equity indexes were higher ahead of Monday's close, as markets assessed comments by a Federal Reserve official. The Nasdaq Composite was up 0.9% at 16,296.2, while the S&P 500 rose 0.7% to 5,165.8. The Dow Jones Industrial Average advanced 0.2% to 38,765.5. Among sectors, technology and communication services led the gainers....
US STOCKS-Wall Street gains as investors renew hopes for Fed rate cuts
US STOCKS-Wall Street gains as investors renew hopes for Fed rate cuts
May 6, 2024
* Focus on Fed speakers after Friday's payrolls data * Paramount Global ( PARAA ) up as bidders await word from special committee * Tyson Foods ( TSN ) shares sink on worries over consumer demand * Spirit Airlines ( SAVE ) drops to record low after earnings * Indexes up: Dow 0.34%, S&P 0.71%, Nasdaq 0.81% (Updated at 1758...
Sector Update: Health Care
Sector Update: Health Care
May 6, 2024
03:36 PM EDT, 05/06/2024 (MT Newswires) -- Health care stocks rose late Monday afternoon with the NYSE Health Care Index adding 0.5% and the Health Care Select Sector SPDR Fund (XLV) up 0.2%. The iShares Biotechnology ETF (IBB) fell 0.2%. In corporate news, GlycoMimetics ( GLYC ) shares plunged 82% after the company said a late-stage study of uproleselan plus...
Copyright 2023-2026 - www.financetom.com All Rights Reserved